{"id":"NCT00146328","sponsor":"Boehringer Ingelheim","briefTitle":"Rollover Trial Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV 1 Infected Subjects","officialTitle":"A Long Term Open Label Rollover Trial Assessing the Safety and Tolerability of Combination Tipranavir and Ritonavir Use in HIV-1 Infected Subjects","status":"COMPLETED","phase":"PHASE2","dates":{"start":"2001-04","primaryCompletion":"2008-05","completion":null,"firstPosted":"2005-09-07","resultsPosted":"2009-07-16","lastUpdate":"2014-03-06"},"enrollment":997,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["HIV Infections"],"interventions":[{"type":"DRUG","name":"Tipranavir","otherNames":[]}],"arms":[{"label":"Group 1","type":"EXPERIMENTAL"},{"label":"Group 2","type":"EXPERIMENTAL"},{"label":"Group 3","type":"EXPERIMENTAL"}],"summary":"The objective of this study is to determine the long term safety and tolerability of multiple oral doses of tipranavir (Aptivus) and ritonavir with a focus on the long term safety of the development dose (500 mg tipranavir/200 mg ritonavir BID) when administered with other antiretroviral medications.","primaryOutcome":{"measure":"Number of Patients With Division of Acquired Immunodeficiency Syndrome (DAIDS) Grade 3 or 4 - Haemoglobin","timeFrame":"End of Trial (>288 weeks)","effectByArm":[{"arm":"Group 1 (Patients With Varying Degrees of Treatment Experience","deltaMin":1,"sd":null},{"arm":"Group 2 (Highly Treatment Experienced Patients)","deltaMin":2,"sd":null},{"arm":"Group 3 (Tipranavir na√Øve Patients)","deltaMin":6,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":233,"countries":["United States","Argentina","Australia","Austria","Belgium","Brazil","Canada","Denmark","France","Germany","Greece","Italy","Mexico","Netherlands","Portugal","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":100},"commonTop":["Diarrhoea","Nausea","Fatigue","Headache","Nasopharyngitis"]}}